Skip to main content
FOCIS 2025 Main banner
Final Program


Final Program

Cancer Immunity & Immunotherapy Course (Separate Registration Required)

Tuesday, June 24, 2025
8:00am - 5:15pm East Coast USA Time
Location: Provincetown

    Co-Chair(s)

  • Asha B. Pillai, MD

    Chair, Hematology and Transplantation, Global Development Scientific Council
    Regeneron Therapeutics Inc
    Tarrytown, New York, United States

  • Stephanie Dougan, PhD

    Dana-Farber Cancer Institute

    • Faculty(s)

  • Michael Dougan, MD, PhD

    Assistant Professor
    Massachusetts General Hospital
    Boston, Massachusetts, United States

Morning Session: Parallel Track in Both Rooms

Group 1 – Gloucester (Michael)
Group 2 – Provincetown (Stephanie)

7:30-8:00 am Introduction Section
8:00-9:00 am Tumor Microenvironment (TME) (Stephanie & Michael)
9:00-10:00 am Tumor Intrinsic Means of Escape (Stephanie & Michael)
10:00-10:15 am Coffee Break – outside Gloucester
10:15-11:15 am Cellular Therapies (Stephanie & Michael)
11:15-12:15 pm Cytokine Directed therapies – blockade and cytokines as drugs (Stephanie & Michael)
12:15-1:00 pm Lunch on their own

Afternoon Session: Split Schedule

Room A – Gloucester
Room B - Provincetown

Group 1
1:00-2:00 pm Lessons Learned from Clinical Trials (Stephanie)
2:00-3:00 pm Bispecifics & Other Targeting Agents (Stephanie)

Group 2
1:00-3:00 pm Immune-related Adverse Events (Michael)

3:00-3:15 pm Coffee Break - outside main room (Gloucester) – groups will switch rooms

Group 1
3:15-5:15 pm Immune-related Adverse Events (Michael)

Group 2
3:15-4:15 pm Lessons Learned from Clinical Trials (Stephanie)
4:15-5:15 pm Bispecifics & Other Targeting Agents (Stephanie)